Correspondence to Professor Steven M McPhail, Australian Centre for Health Services Innovation, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia; steven.mcphail{at}qut.edu.au ...
Kodiak Sciences Inc said on Wednesday results from a mid-to-late stage trial failed to show non-inferiority of its experimental eye drug KSI-301 compared to Regeneron Pharmaceuticals' Eylea. The views ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback